RXRX vs MPLT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

RXRX

44.1
AI Score
VS
RXRX Wins

MPLT

31.4
AI Score

Investment Advisor Scores

RXRX

44score
Recommendation
HOLD

MPLT

31score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric RXRX MPLT Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -60.1% 0.0% MPLT
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 44.1/100 31.4/100 RXRX
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation HOLD EXTENDED Tie

Relative Price Performance (Last 90 Days)

RXRX 1M: -2.7% · 3M: +1.6% MPLT 1M: +14.2% · 3M: -57.2%

Current Technical Phase

RXRX

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope 0.1%) with fading momentum, RSI 46

RSI (14): 45.6 · Price: $3.20

MPLT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -25.7%), weak momentum, RSI 40

RSI (14): 40.1 · Price: $13.00

Fundamentals Snapshot

Metric RXRX MPLT
Market Cap
Forward P/E -3.6 -3.9
Trailing P/E
Revenue (TTM)
Revenue Growth -0.6% 0.0%
Gross Margin -7.2%
Operating Margin -17.6% 0.0%
EPS -0.98 -20.22
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, RXRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.